FI20010868A0 - Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi - Google Patents

Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Info

Publication number
FI20010868A0
FI20010868A0 FI20010868A FI20010868A FI20010868A0 FI 20010868 A0 FI20010868 A0 FI 20010868A0 FI 20010868 A FI20010868 A FI 20010868A FI 20010868 A FI20010868 A FI 20010868A FI 20010868 A0 FI20010868 A0 FI 20010868A0
Authority
FI
Finland
Prior art keywords
test
induced diseases
methods
autoantigen
liberated
Prior art date
Application number
FI20010868A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Markku Maeki
Ilma Korponay-Szabo
Original Assignee
Markku Maeki
Korponay Szabo Ilma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8561063&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20010868(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Markku Maeki, Korponay Szabo Ilma filed Critical Markku Maeki
Priority to FI20010868A priority Critical patent/FI20010868A0/fi
Publication of FI20010868A0 publication Critical patent/FI20010868A0/fi
Priority to DE60229513T priority patent/DE60229513D1/de
Priority to EP02718225A priority patent/EP1390753B1/en
Priority to HU0400066A priority patent/HU229679B1/hu
Priority to AT02718225T priority patent/ATE412180T1/de
Priority to PL366996A priority patent/PL208039B1/pl
Priority to CA2445102A priority patent/CA2445102C/en
Priority to BRPI0209172A priority patent/BRPI0209172B8/pt
Priority to ES02718225T priority patent/ES2314043T3/es
Priority to PCT/FI2002/000340 priority patent/WO2002086509A1/en
Priority to US10/475,786 priority patent/US7361480B2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20010868A 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi FI20010868A0 (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
US10/475,786 US7361480B2 (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases
PCT/FI2002/000340 WO2002086509A1 (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases
HU0400066A HU229679B1 (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases
EP02718225A EP1390753B1 (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases
DE60229513T DE60229513D1 (de) 2001-04-25 2002-04-24 Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
AT02718225T ATE412180T1 (de) 2001-04-25 2002-04-24 Verfahren und mittel zum nachweis von durch gluten induzierten krankheiten
PL366996A PL208039B1 (pl) 2001-04-25 2002-04-24 Sposób wykrywania celiakii (CD) lub opryszczkowego zapalenia skóry w próbce krwi pacjenta lub w zhemolizowanej próbce krwi pacjenta i zastosowanie transglutaminazy tkankowej (tTG) uwolnionej z czerwonych krwinek (RBC) z próbki krwi
CA2445102A CA2445102C (en) 2001-04-25 2002-04-24 Method and means for detecting gluten-induced diseases
BRPI0209172A BRPI0209172B8 (pt) 2001-04-25 2002-04-24 método de detecção de doenças induzidas por glúten em uma amostra sanguínea de um indivíduo, e kit teste para uso no método
ES02718225T ES2314043T3 (es) 2001-04-25 2002-04-24 Procedimiento y medio para detectar enfermedades inducidas por el gluten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Publications (1)

Publication Number Publication Date
FI20010868A0 true FI20010868A0 (fi) 2001-04-25

Family

ID=8561063

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010868A FI20010868A0 (fi) 2001-04-25 2001-04-25 Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Country Status (11)

Country Link
US (1) US7361480B2 (pl)
EP (1) EP1390753B1 (pl)
AT (1) ATE412180T1 (pl)
BR (1) BRPI0209172B8 (pl)
CA (1) CA2445102C (pl)
DE (1) DE60229513D1 (pl)
ES (1) ES2314043T3 (pl)
FI (1) FI20010868A0 (pl)
HU (1) HU229679B1 (pl)
PL (1) PL208039B1 (pl)
WO (1) WO2002086509A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
GB0117870D0 (en) 2001-07-21 2001-09-12 Univ Nottingham Trent Method of diagnosis and kit of parts therefor
GB0304993D0 (en) * 2003-03-05 2003-04-09 Univ Nottingham Trent Novel screening method
FR2857453B1 (fr) * 2003-07-11 2007-04-20 Covalab Procede de detection serologique de la maladie coeliaque et necessaire de diagnostic associe
BRPI0922122A2 (pt) 2008-11-30 2017-08-01 Immusant Inc composições e métodos para tratamento de doença celíaca.
WO2015038624A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE461616B (sv) * 1987-05-08 1990-03-05 Biocarb Ab Foerfarande och testsats vid diagnos av iga nefropati med bestaemning av fibronektin-iga-komplex
US5200344A (en) * 1990-11-13 1993-04-06 Blaser Martin J Diagnostic testing for campylobacter jejuni or campylobacter coli infections using novel antigens
WO1994020857A1 (en) * 1993-03-11 1994-09-15 The Regents Of The University Of California Assay for humoral immunity to macromolecules
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
WO2001001133A2 (en) * 1999-06-28 2001-01-04 Immundiagnostik Ag Diagnosis of gluten sensitive enteropathy and other autoimmunopathies
US6703208B1 (en) * 1999-10-20 2004-03-09 Immco Diagnostics Immunological assay for detection of antibodies in celiac disease
FI20010868A0 (fi) * 2001-04-25 2001-04-25 Markku Maeki Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi

Also Published As

Publication number Publication date
HU229679B1 (en) 2014-04-28
US7361480B2 (en) 2008-04-22
ATE412180T1 (de) 2008-11-15
DE60229513D1 (de) 2008-12-04
BRPI0209172B1 (pt) 2017-06-06
US20040115750A1 (en) 2004-06-17
ES2314043T3 (es) 2009-03-16
PL208039B1 (pl) 2011-03-31
WO2002086509A8 (en) 2003-01-16
EP1390753A2 (en) 2004-02-25
HUP0400066A2 (hu) 2004-04-28
BRPI0209172B8 (pt) 2021-07-27
PL366996A1 (pl) 2005-02-07
HUP0400066A3 (en) 2006-01-30
CA2445102C (en) 2012-01-03
BR0209172A (pt) 2004-08-03
WO2002086509A1 (en) 2002-10-31
EP1390753B1 (en) 2008-10-22
CA2445102A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
WO2010027903A8 (en) Lung cancer diagnosis
MX2009013388A (es) Analisis multiple de muestras de sangre.
DE69940436D1 (de) Prostata stammzellantigen (psca) und dessen verwendungen
BR0306712A (pt) Sistema e método para avaliação das condições neurológicas usando biespectro de eeg
DE60030281D1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
WO2007117444A3 (en) Protein detection by aptamers
TW200801202A (en) Alpha-enolase specific antibody and method of use
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
NO982265L (no) Diagnostikk for og mediatorer for inflammatoriske forstyrrelser
DE602006012995D1 (de) Brustkrebsdiagnoseverfahren
MX2013008471A (es) Metodos y aparatos para la deteccion de sensibilidad al gluten y su diferenciacion de la enfermedad celiaca.
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
CA3139535A1 (en) Methods and systems for detecting residual disease
FI20010868A0 (fi) Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
WO2007103211A3 (en) Methods to identify fat and lean animals using class predictors
ATE479778T1 (de) Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8
FI20031370A0 (fi) Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan
DK0991945T4 (da) Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum
GB0126319D0 (en) Microfluidic serrs detection
Álvarez-Fernández et al. Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients
WO2023003647A9 (en) Methods for determining variant frequency and monitoring disease progression
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs